Double dose hope: new stroke study tests second clot buster
NCT ID NCT07375966
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at giving a second dose of the clot-busting drug tenecteplase to people having a stroke caused by a medium or large blocked artery. Participants must receive the first dose within 4.5 hours of symptoms and show little improvement after one hour. The goal is to see if the extra dose helps reopen the artery and improve recovery without causing harm.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE WITH LARGE OR MEDIUM VESSEL OCCLUSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Lu Wang
RECRUITINGShenyang, Liaoning, 110840, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Zapping the brain to restore swallowing after stroke?
- Can Brain-Triggered stimulation reawaken arms after stroke?
- Can lifestyle choices after a stroke extend life and prevent a second one?
- Can Clot-Removing devices improve stroke recovery?
- A tiny neck implant could catch Stroke-Causing clots before they reach the brain
- Can virtual games retrain the brain to restore balance?